Descrizione

According to a report by StrategyHelix, the global 3d bioprinting market is set to increase by US$ 1,538.1 milioni durante 2022-2028, growing at a CAGR of 17.3% durante il periodo di previsione.

Il rapporto fornisce dati aggiornati sulle dimensioni del mercato per il periodo 2018-2021 e previsione a 2028 covering key market aspects like sales value for 3d bioprinting. The global 3d bioprinting market is segmented on the basis of components, tecnologia, material, applicazione, end user, e regione. On the basis of components, the global 3d bioprinting market has been segmented into 3D bioprinters, bioinks. Per tecnologia, the global 3d bioprinting market has been segmented into inkjet bioprinting, laser assisted bioprinting, magnetic levitation bioprinting, syringe/extrusion bioprinting, altri. Based on material, the global 3d bioprinting market is categorized into extracellular matrices, hydrogels, living cells, altri. On the basis of application, the global 3d bioprinting market has been segmented into clinical, research. By end user, the global 3d bioprinting market has been segmented into biopharmaceutical companies, regenerative medicine companies, research organizations & academic institutes, altri. Geograficamente, the global 3d bioprinting market is segmented into Asia Pacific, Europa, Nord America, Rest of the World (RoW).

The global 3d bioprinting market is highly competitive. The prominent players operating in the global 3d bioprinting market include 3D Systems Corporation (Allevi Inc.), Advanced Solutions Life Sciences LLC (ASLS), Aspect Biosystems Ltd., BICO Group AB (Formerly Cellink AB), Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSIM GmbH, Inventia Life Science Pty Ltd., Nano3D Biosciences Inc. (n3D), Organovo Holdings Inc., Poietis SAS, regenHU Ltd., Regenovo Biotechnology Co. Ltd., ROKIT Healthcare INC., Stratasys Ltd., Vivax Bio LLC (3D Bioprinting Solutions). Competitive landscape gives a description of the competitive nature of the global 3d bioprinting market and a description of the leading companies. Vengono individuati i principali accordi finanziari che hanno plasmato il mercato negli ultimi anni.

Il rapporto è una risorsa inestimabile per le aziende e le organizzazioni attive in questo settore. It provides a cohesive picture of the 3d bioprinting market to help drive informed decision making for industry executives, decisori politici, accademico, e analisti.

Ambito del rapporto

Componenti: 3D bioprinters, bioinks
Tecnologia: inkjet bioprinting, laser assisted bioprinting, magnetic levitation bioprinting, syringe/extrusion bioprinting, altri
Material: extracellular matrices, hydrogels, living cells, altri
Applicazione: clinical, research
Utente finale: biopharmaceutical companies, regenerative medicine companies, research organizations & academic institutes, altri
Regione: Asia Pacifico, Europa, Nord America, Rest of the World (RoW)
Anni considerati: la presente relazione copre il periodo 2018 A 2028
Azienda menzionata: 3D Systems Corporation (Allevi Inc.), Advanced Solutions Life Sciences LLC (ASLS), Aspect Biosystems Ltd., BICO Group AB (Formerly Cellink AB), Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSIM GmbH, Inventia Life Science Pty Ltd., Nano3D Biosciences Inc. (n3D), Organovo Holdings Inc., Poietis SAS, regenHU Ltd., Regenovo Biotechnology Co. Ltd., ROKIT Healthcare INC., Stratasys Ltd., Vivax Bio LLC (3D Bioprinting Solutions)

Principali vantaggi per gli stakeholder

– Get a comprehensive picture of the global 3d bioprinting market
– Identificare le strategie regionali e le priorità strategiche sulla base dei dati locali
– Individuare i settori in crescita e le tendenze per gli investimenti

Sommario

Parte 1. introduzione
– Ambito dello studio
– Periodo di studio
– Ambito geografico
– Metodologia di ricerca
Parte 2. 3d bioprinting market overview
Parte 3. Market breakdown by components
– 3D bioprinters
– Bioinks
Parte 4. Market breakdown by technology
– Inkjet bioprinting
– Laser assisted bioprinting
– Magnetic levitation bioprinting
– Syringe/extrusion bioprinting
– Altri
Parte 5. Market breakdown by material
– Extracellular matrices
– Hydrogels
– Living cells
– Altri
Parte 6. Market breakdown by application
– Clinical
– Research
Parte 7. Market breakdown by end user
– Biopharmaceutical companies
– Regenerative medicine companies
– Research organizations & academic institutes
– Altri
Parte 8. Market breakdown by region
– Asia Pacifico
– Europa
– Nord America
– Rest of the World (RoW)
Parte 9. Aziende chiave
– 3D Systems Corporation (Allevi, Inc.)
– Advanced Solutions Life Sciences, LLC (ASLS)
– Aspect Biosystems Ltd.
– BICO Group AB (Formerly Cellink AB)
– Cyfuse Biomedical K.K.
– EnvisionTEC GmbH (Desktop Metal Inc.)
– GeSIM GmbH
– Inventia Life Science Pty Ltd.
– Nano3D Biosciences, Inc. (n3D)
– Organovo Holdings Inc.
– Poietis SAS
– regenHU Ltd.
– Regenovo Biotechnology Co., Ltd.
– ROKIT Healthcare, INC.
– Stratasys Ltd.
– Vivax Bio, LLC (3D Bioprinting Solutions)
Informazioni su StrategyHelix
Disclaimer